Embecta Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMBC research report →
Companywww.embecta.com
Embecta Corp. , a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.
- CEO
- Devdatt Kurdikar
- IPO
- 2022
- Employees
- 2,000
- HQ
- Parsippany, NJ, US
Price Chart
Valuation
- Market Cap
- $181.54M
- P/E
- 1.59
- P/S
- 0.17
- P/B
- -0.28
- EV/EBITDA
- 4.07
- Div Yield
- 19.61%
Profitability
- Gross Margin
- 62.52%
- Op Margin
- 29.78%
- Net Margin
- 10.73%
- ROE
- -17.49%
- ROIC
- 25.77%
Growth & Income
- Revenue
- $1.08B · -3.80%
- Net Income
- $95.40M · 21.84%
- EPS
- $1.64 · 20.59%
- Op Income
- $329.30M
- FCF YoY
- 816.58%
Performance & Tape
- 52W High
- $15.55
- 52W Low
- $2.77
- 50D MA
- $7.80
- 200D MA
- $11.48
- Beta
- 1.05
- Avg Volume
- 1.70M
Get TickerSpark's AI analysis on EMBC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 11, 26 | Anderson Carrie L | other | 22,841 |
| Feb 11, 26 | HOMBACH ROBERT J. | other | 22,841 |
| Feb 11, 26 | Morris Milton Mayo | other | 22,841 |
| Feb 11, 26 | Prange Karen | other | 22,841 |
| Feb 11, 26 | Pomeroy Claire | other | 22,841 |
| Feb 11, 26 | Reidy Christopher R | other | 22,841 |
| Nov 26, 25 | Mann Jeffrey Z | other | 0 |
| Nov 26, 25 | Elguicze Jacob | other | 0 |
| Nov 26, 25 | Roth Anthony M. | other | 32,817 |
| Nov 26, 25 | Roth Anthony M. | other | 1,881 |
Our EMBC Coverage
We haven't published any research on EMBC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EMBC Report →